Your browser doesn't support javascript.
loading
Design and rationale of randomized evaluation of decreased usage of beta-blockers after acute myocardial infarction (REDUCE-AMI).
Yndigegn, Troels; Lindahl, Bertil; Alfredsson, Joakim; Benatar, Jocelyne; Brandin, Lisa; Erlinge, David; Haaga, Urban; Held, Claes; Johansson, Pelle; Karlström, Patric; Kellerth, Thomas; Marandi, Toomas; Mars, Katarina; Ravn-Fischer, Annica; Sundström, Johan; Östlund, Ollie; Hofmann, Robin; Jernberg, Tomas.
Afiliación
  • Yndigegn T; Department of Cardiology, Clinical Sciences, Skane University Hospital, Lund University, 222 42 Lund, Sweden.
  • Lindahl B; Department of Medical Sciences, Cardiology, Uppsala University, 751 05 Uppsala, Sweden.
  • Alfredsson J; Department of Cardiology Department of Health, Medicine and Caring Sciences, Linköping University, 581 83 Linköping, Sweden.
  • Benatar J; Department of Cardiology, Green Lane Cardiovascular Service, Auckland City Hospital, 1051 Auckland, New Zealand.
  • Brandin L; Division of Cardiology, Skaraborgs sjukhus Skövde, 541 42 Skövde, Sweden.
  • Erlinge D; Department of Cardiology, Clinical Sciences, Skane University Hospital, Lund University, 222 42 Lund, Sweden.
  • Haaga U; Division of Cardiology and Emergency Medicine, Centralsjukhuset Karlstad, 651 85 Karlstad, Sweden.
  • Held C; Department of Medical Sciences, Cardiology, Uppsala University, 751 05 Uppsala, Sweden.
  • Johansson P; Heart and Lung Patients Association, 111 27 Stockholm, Sweden.
  • Karlström P; Division of Cardiology, Department of Internal Medicine, Ryhov Hospital, 553 05 Jönköping, Sweden.
  • Kellerth T; Division of Cardiology and Emergency Medicine, Centralsjukhuset Karlstad, 651 85 Karlstad, Sweden.
  • Marandi T; Department of Cardiology, University of Tartu, 50406 Tartu, Centre of Cardiology, North Estonia Medical Centre, Tallinn, Estonia.
  • Mars K; Department of Clinical Science and Education, Division of Cardiology, Karolinska Institutet, Södersjukhuset, 118 83 Stockholm, Sweden.
  • Ravn-Fischer A; Department of Cardiology, Sahlgrenska University Hospital Institute of Medicine, Department of Molecular and Clinical Medicine Sahlgrenska, Academy at University of Gothenburg, 413 45 Gothenburg, Sweden.
  • Sundström J; Department of Medical Sciences, Cardiology, Uppsala University, 751 05 Uppsala, Sweden.
  • Östlund O; The George Institute for Global Health, University of New South Wales, 2052 Sydney, Australia.
  • Hofmann R; Department of Medical Sciences, Cardiology, Uppsala University, 751 05 Uppsala, Sweden.
  • Jernberg T; Department of Clinical Science and Education, Division of Cardiology, Karolinska Institutet, Södersjukhuset, 118 83 Stockholm, Sweden.
Eur Heart J Cardiovasc Pharmacother ; 9(2): 192-197, 2023 02 02.
Article en En | MEDLINE | ID: mdl-36513329
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 / 2_ODS3 / 6_ODS3_enfermedades_notrasmisibles Problema de salud: 1_doencas_nao_transmissiveis / 2_muertes_prematuras_enfermedades_notrasmisibles / 6_asthma / 6_cardiovascular_diseases / 6_chronic_obstructive_pulmonary_disease / 6_ischemic_heart_disease / 6_other_circulatory_diseases Asunto principal: Calidad de Vida / Infarto del Miocardio Tipo de estudio: Clinical_trials / Guideline Aspecto: Patient_preference Límite: Humans Idioma: En Revista: Eur Heart J Cardiovasc Pharmacother Año: 2023 Tipo del documento: Article País de afiliación: Suecia
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 / 2_ODS3 / 6_ODS3_enfermedades_notrasmisibles Problema de salud: 1_doencas_nao_transmissiveis / 2_muertes_prematuras_enfermedades_notrasmisibles / 6_asthma / 6_cardiovascular_diseases / 6_chronic_obstructive_pulmonary_disease / 6_ischemic_heart_disease / 6_other_circulatory_diseases Asunto principal: Calidad de Vida / Infarto del Miocardio Tipo de estudio: Clinical_trials / Guideline Aspecto: Patient_preference Límite: Humans Idioma: En Revista: Eur Heart J Cardiovasc Pharmacother Año: 2023 Tipo del documento: Article País de afiliación: Suecia